Royce & Associates LP Has $3.90 Million Stake in Silicon Laboratories, Inc. $SLAB

Royce & Associates LP raised its position in Silicon Laboratories, Inc. (NASDAQ:SLABFree Report) by 24.0% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 29,757 shares of the semiconductor company’s stock after buying an additional 5,751 shares during the quarter. Royce & Associates LP owned about 0.09% of Silicon Laboratories worth $3,902,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in the company. AQR Capital Management LLC increased its stake in Silicon Laboratories by 43.7% in the first quarter. AQR Capital Management LLC now owns 17,892 shares of the semiconductor company’s stock valued at $2,001,000 after acquiring an additional 5,439 shares during the last quarter. Millennium Management LLC lifted its stake in Silicon Laboratories by 2,804.1% during the first quarter. Millennium Management LLC now owns 99,842 shares of the semiconductor company’s stock worth $11,239,000 after purchasing an additional 96,404 shares during the last quarter. Jones Financial Companies Lllp boosted its holdings in shares of Silicon Laboratories by 121.4% in the 1st quarter. Jones Financial Companies Lllp now owns 496 shares of the semiconductor company’s stock valued at $56,000 after purchasing an additional 272 shares in the last quarter. United Services Automobile Association bought a new position in shares of Silicon Laboratories in the 1st quarter valued at $235,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in shares of Silicon Laboratories by 1.8% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 97,156 shares of the semiconductor company’s stock valued at $10,937,000 after purchasing an additional 1,679 shares during the last quarter.

Analysts Set New Price Targets

Several research firms recently weighed in on SLAB. Benchmark lowered Silicon Laboratories from a “buy” rating to a “hold” rating in a research note on Wednesday, February 4th. Needham & Company LLC cut shares of Silicon Laboratories from a “buy” rating to a “hold” rating in a report on Wednesday, February 4th. KeyCorp downgraded shares of Silicon Laboratories from an “overweight” rating to a “hold” rating in a research note on Wednesday, February 4th. Citigroup upped their price objective on shares of Silicon Laboratories from $135.00 to $231.00 and gave the stock a “neutral” rating in a research report on Friday, February 6th. Finally, Royal Bank Of Canada increased their price objective on shares of Silicon Laboratories from $160.00 to $205.00 and gave the company a “sector perform” rating in a research note on Thursday, February 5th. One research analyst has rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Silicon Laboratories currently has a consensus rating of “Hold” and a consensus target price of $167.78.

Get Our Latest Report on SLAB

Insider Activity at Silicon Laboratories

In related news, Director Nina Richardson sold 1,355 shares of the business’s stock in a transaction on Tuesday, January 13th. The shares were sold at an average price of $149.00, for a total value of $201,895.00. Following the sale, the director owned 8,543 shares of the company’s stock, valued at $1,272,907. The trade was a 13.69% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Company insiders own 1.60% of the company’s stock.

Silicon Laboratories Price Performance

Silicon Laboratories stock opened at $203.25 on Friday. The business has a 50 day moving average of $170.21 and a 200-day moving average of $145.65. The company has a market capitalization of $6.70 billion, a P/E ratio of -102.14 and a beta of 1.46. Silicon Laboratories, Inc. has a 1 year low of $82.82 and a 1 year high of $208.84.

Silicon Laboratories (NASDAQ:SLABGet Free Report) last posted its earnings results on Wednesday, February 4th. The semiconductor company reported $0.56 EPS for the quarter, topping the consensus estimate of $0.54 by $0.02. Silicon Laboratories had a negative net margin of 8.27% and a negative return on equity of 4.07%. The business had revenue of $208.21 million for the quarter, compared to the consensus estimate of $207.63 million. During the same period last year, the company earned ($0.11) EPS. The firm’s revenue was up 25.3% compared to the same quarter last year. Equities analysts anticipate that Silicon Laboratories, Inc. will post -0.97 EPS for the current year.

Silicon Laboratories Company Profile

(Free Report)

Silicon Laboratories (NASDAQ:SLAB) is a global semiconductor company that develops high-performance analog and mixed-signal integrated circuits, wireless system-on-chips (SoCs), microcontrollers, and radio frequency (RF) solutions. Its product portfolio is tailored to support the Internet of Things (IoT), infrastructure, industrial automation, consumer electronics, automotive, and energy markets. By combining silicon, software, and tools, Silicon Labs aims to accelerate development cycles and deliver low-power, highly integrated solutions that address demanding application requirements.

Founded in 1996 and headquartered in Austin, Texas, Silicon Labs has grown into a multinational organization with engineering and sales operations across North America, Europe, and Asia.

Featured Articles

Want to see what other hedge funds are holding SLAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Silicon Laboratories, Inc. (NASDAQ:SLABFree Report).

Institutional Ownership by Quarter for Silicon Laboratories (NASDAQ:SLAB)

Receive News & Ratings for Silicon Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silicon Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.